Featured Image of Top News Story: Bariatric surgery reduces costs for patients with type 2 diabetes

Bariatric surgery reduces costs for patients with type 2 diabetes

A Kaiser Permanente found that bariatric surgery reduced health care costs for adults with type 2 diabetes and obesity. The study was published in the Annals of Internal Medicine in February 2025. “The study shows that both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) help reduce ...

  • Many U.S. teens may be eligible for weight loss surgery

    March 1, 2025
    In a Kaiser Permanente Southern California study, 1 in 23 adolescents met the eligibility criteria for metabolic and bariatric surgery, also known as weight loss surgery. The findings suggest that about 1 million adolescents across the United States could be eligible for the procedure. “Understanding the population of adolescents who qualify for weight loss surgery is ...
    Read more...
  • Study highlights the impact of electronic media use on young people

    January 6, 2025
    Young people who frequently used electronic media, such as computers, television, and social media, had less physical activity, more stress, and modest cognitive challenges. The study was published in January 2025 in Preventive Medicine. “Our research found an association between electronic media use and a negative impact on youth,” said the study’s lead author,  Deborah Cohen, ...
    Read more...
  • New study sheds light on incidence of IgA nephropathy

    January 6, 2025
    A recent Kaiser Permanente study described the incidence of IgA nephropathy, an autoimmune kidney disease, nationally, as well as among people of different race and ethnicities. The study was published in the American Journal of Nephrology in November 2024. “IgA nephropathy is a rare disease. Attempts to determine its incidence in the United States have relied ...
    Read more...
  • RSV vaccine protects older adults against severe illness

    December 16, 2024
    A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. “This Kaiser Permanente research demonstrated the real-world effectiveness of RSV vaccination among those 60 and over,” said lead author Sara Y. Tartof, PhD, MPH, ...
    Read more...
  • Study finds air pollution may increase risk of preterm birth

    December 2, 2024
    Exposure to a specific kind of air pollution, fine particulate matter, during pregnancy may significantly increase the risk of spontaneous preterm birth, which can be dangerous for both the mother and the baby, according to a Kaiser Permanente study published in JAMA Network Open. “Consistent with other study findings, this current study has demonstrated that there ...
    Read more...
  • 5 questions for … Dr. Javed Sheikh

    November 22, 2024
    Javed Sheikh, MD, was recently named 2024 Physician Researcher of the Year by the Southern California Permanente Medical Group. Dr. Sheikh is the vice area research chair for the Los Angeles area on the Regional Research Committee. He is chief of the Department of Allergy and Immunology at the Kaiser Permanente Los Angeles Medical Center and ...
    Read more...
  • Kaiser Permanente’s vaccine side-effect monitor bolsters safety

    November 22, 2024
    After COVID-19 vaccines became available in December 2020, several smartphone-based reporting systems were developed to monitor vaccine side effects. They included V-safe from the Centers for Disease Control and Prevention. However, like most large surveillance systems, they had imperfections. Kaiser Permanente Southern California collaborated with the CDC and others to create a new system in April ...
    Read more...
  • Five questions for … Dr. Kristi Reynolds

    November 22, 2024
    Kristi Reynolds, PhD, MPH, is a chronic disease epidemiologist and the director of the Division of Epidemiologic Research for the Department of Research & Evaluation. Her research focuses on the prevention and treatment of hypertension, dyslipidemia, diabetes, and cardiovascular disease. She also studies medication adherence, drug safety, and cardiovascular quality of care and outcomes. Dr. Reynolds has more than ...
    Read more...
  • No link between COVID-19 vaccines and cardiac-related death

    November 22, 2024
    Research conducted at Kaiser Permanente has provided reassurance to the public and lawmakers by refuting claims that COVID-19 vaccines may increase the risk of cardiac-related death. “Our work reaffirms the previously established safety of COVID-19 vaccines,” said lead author Stanley Xu, PhD, of the Kaiser Permanente Southern California Department of Research & Evaluation. The study addressed concerns raised ...
    Read more...
  • People with new-onset heart failure benefit from testing for coronary artery disease

    November 22, 2024
    A new Kaiser Permanente study explores factors that might influence whether people with new-onset heart failure get tested for coronary artery disease. Published November 1, 2024, in JACC: Advances, it suggests that physician perceptions of the risks and benefits of testing, patient preferences, and socioeconomic challenges may all come into play. The study follows research published ...
    Read more...